A Prospective, Non-randomised, Single-arm, Open-Label Pilot Clinical Study Evaluating the Effect of PTH Lowering on Erythropoietin Consumption in Calcitriol-Resistant Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01506947

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:05.056568+00:00

Published At

2017-05-15T00:00:00+00:00

Record Updated At

2021-07-30

Results Posted At

2017-05-15

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Moderate to Severe Secondary Hyperparathyroidism", "Stage 5 Chronic Kidney Diseases"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2021-07-30"

protocolSection.identificationModule.nctId

"NCT01506947"

protocolSection.identificationModule.officialTitle

"A Prospective, Non-randomised, Single-arm, Open-Label Pilot Clinical Study Evaluating the Effect of PTH Lowering on Erythropoietin Consumption in Calcitriol-Resistant Patients"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-05-15"

Study condition terms

• Moderate to Severe Secondary Hyperparathyroidism (protocolSection.conditionsModule.conditions)
• Stage 5 Chronic Kidney Diseases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.